Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models

Background Malignant gliomas (MGs) are the most common primary brain malignancies and are considered universally fatal. Oncolytic herpes simplex viruses (oHSVs) are promising immunotherapeutics capable of selectively lysing cancer cells, eliciting antitumor immunity, and providing local delivery of...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Alexia K Martin, Uksha Saini, Ilse Hernandez-Aguirre, Yeaseul Kim, Kevin A Cassady, Jack Hedberg, Doyeon Kim, Ravi Dhital
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 2025-07-01
Schriftenreihe:	Journal for ImmunoTherapy of Cancer
Online-Zugang:	https://jitc.bmj.com/content/13/7/e012227.full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!